Skip to content

Keith Slotkin

Executive Officer, Director at Spearhead Bio.

Raised on Spearhead Bio filings

$1.2M

of $1.8M offered across 1 Form D filing

Form D filings
1
Teammates
3
Last filing
Jun 23, 2026

Company

Spearhead Bio

Biotech · Saint Louis, MO

Gene insertion tools for crop genome editing

Investors
4
Founded
2024
Still open
$550K

Spearhead Bio filings

  • Security to be acquiredFiled Jun 23, 2026Form D
    $1.2M/ $1.8M

Works with